Compare LIVN & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIVN | LAZ |
|---|---|---|
| Founded | 1987 | 1848 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2015 | 2004 |
| Metric | LIVN | LAZ |
|---|---|---|
| Price | $78.17 | $44.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 8 |
| Target Price | ★ $72.43 | $52.75 |
| AVG Volume (30 Days) | 622.0K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.40 | ★ 0.91 |
| Revenue | N/A | ★ $3,186,466,000.00 |
| Revenue This Year | $9.79 | $13.36 |
| Revenue Next Year | $6.63 | $13.72 |
| P/E Ratio | $196.53 | ★ $47.31 |
| Revenue Growth | N/A | ★ 1.48 |
| 52 Week Low | $41.02 | $38.67 |
| 52 Week High | $85.27 | $58.75 |
| Indicator | LIVN | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.69 | 53.66 |
| Support Level | $61.63 | $39.43 |
| Resistance Level | $80.96 | $45.20 |
| Average True Range (ATR) | 2.31 | 2.10 |
| MACD | -0.78 | 0.32 |
| Stochastic Oscillator | 27.67 | 77.62 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.